Spontaneous production of eosinophil chemotactic factors by T lymphocytes from patients with subcutaneous angioblastic lymphoid hyperplasia with eosinophilia. 1986

M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura

Subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (SALH) was reviewed with respect to eosinophil chemotaxis. Lymphoid cells separated from the granuloma spontaneously released at least two different eosinophil chemotactic factors (ECF): low-molecular-weight and high-molecular-weight ECF according to the profile on gel filtration (LMW-ECF, about 500; HMW-ECF, 45,000 to 70,000). The cells, however, failed to produce chemotactic activity for macrophages and neutrophils. By analysis with monoclonal antibodies against lymphocyte subpopulations, the granuloma T cells, probably OKT4-positive cells, were shown to be responsible for spontaneous production of these two ECF. Furthermore, the blood mononuclear leukocytes were separated from the patients with SALH. An ECF closely resembling HMW-ECF was also spontaneously produced by the blood OKT4-positive T lymphocytes, whereas no LMW-ECF was released. Mononuclear leukocytes from healthy donors, however, could produce an ECF resembling HMW-ECF and chemotactic activities for macrophages and neutrophils by stimulation with concanavalin A (Con A). Protein synthesis appeared to be essential for spontaneous ECF and for Con A-induced ECF production. These results suggest that the granuloma OKT4-positive T lymphocytes of the patients with SALH are in activated condition to release LMW- and HMW-ECF, whereas the blood OKT4-positive T lymphocytes are in activated condition to release only HMW-ECF. Such spontaneous and prolonged production of HMW-ECF by the cells can be one of the diagnostic means of SALH.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011691 Puromycin A cinnamamido ADENOSINE found in STREPTOMYCES alboniger. It inhibits protein synthesis by binding to RNA. It is an antineoplastic and antitrypanosomal agent and is used in research as an inhibitor of protein synthesis. CL-13900,P-638,Puromycin Dihydrochloride,Puromycin Hydrochloride,Stylomycin,CL 13900,CL13900,P 638,P638
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D002631 Chemotactic Factors, Eosinophil Cytotaxins liberated from normal or invading cells that specifically attract eosinophils; they may be complement fragments, lymphokines, neutrophil products, histamine or other; the best known is the tetrapeptide ECF-A, released mainly by mast cells. Eosinophil Chemotactic Factors,Eosinophil Chemotaxins,Chemotaxins, Eosinophil,Factors, Eosinophil Chemotactic
D003208 Concanavalin A A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.
D004802 Eosinophilia Abnormal increase of EOSINOPHILS in the blood, tissues or organs. Eosinophilia, Tropical,Hypereosinophilia,Tropical Eosinophilia,Hypereosinophilias,Tropical Eosinophilias
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000796 Angiolymphoid Hyperplasia with Eosinophilia Solitary or multiple benign cutaneous nodules comprised of immature and mature vascular structures intermingled with endothelial cells and a varied infiltrate of eosinophils, histiocytes, lymphocytes, and mast cells. Granuloma, Pseudopyogenic,Pseudopyogenic Granuloma,Granulomas, Pseudopyogenic,Pseudopyogenic Granulomas
D000945 Antigens, Differentiation, T-Lymphocyte Antigens expressed on the cell membrane of T-lymphocytes during differentiation, activation, and normal and neoplastic transformation. Their phenotypic characterization is important in differential diagnosis and studies of thymic ontogeny and T-cell function. Antigens, Differentiation, T-Cell,Differentiation Antigens, T-Cell,L3T4 Antigens,Leu Antigens, T-Lymphocyte,T-Cell Differentiation Antigens,T-Lymphocyte Differentiation Antigens,T6 Antigens,Antigens, Differentiation, T Lymphocyte,Differentiation Antigens, T Lymphocyte,Antigens, L3T4,Antigens, T-Cell Differentiation,Antigens, T-Lymphocyte Differentiation,Antigens, T-Lymphocyte Leu,Antigens, T6,Differentiation Antigens, T Cell,Differentiation Antigens, T-Lymphocyte,Leu Antigens, T Lymphocyte,T Cell Differentiation Antigens,T Lymphocyte Differentiation Antigens,T-Lymphocyte Leu Antigens

Related Publications

M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
February 1972, Cancer,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
January 1994, International archives of allergy and immunology,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
August 1963, Proceedings of the Royal Society of Medicine,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
January 1969, Dermatologica,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
March 1977, Cutis,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
June 1993, Immunology letters,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
January 1969, The British journal of dermatology,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
December 1997, Journal of the Indian Medical Association,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
January 1996, International archives of allergy and immunology,
M Hirashima, and K Sakata, and K Tashiro, and J Ohmori, and K Iyama, and H Tsuda, and T Nagai, and T Hiraoka, and T Kimura
September 1982, Clinical allergy,
Copied contents to your clipboard!